Price Summary

FinStar

Ownership Stable

Ownership strength is slightly missing the benchmark.

ValuationAttractive

The stock is considerably attractive based on intrinsic value.

EfficiencyPoor

The company seems highly inefficient in case of asset management.

FinancialsWeak

Watch out! The company might not be able to sustain any adverse condition.

Company Essentials

Enterprise Value

3475.71 Cr.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

HCG Milann Strand Life Sciences

 Group Companies

Ratios

Sales Growth

1 Year7.47%

3 Year8.09%

5 Year10.38%

Profit Growth

1 Year-835.64%

3 Year-239.85%

5 Year-283.01%

ROE%

1 Year-8.55%

3 Year-1.02%

5 Year-0.12%

ROCE %

1 Year1.62%

3 Year5.13%

5 Year5.1%

Interest Cover Ratio

0.21125623539051

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2021 68.41 3.47
Mar 2021 70.71 3.36
Dec 2020 66.87 0
Sep 2020 66.91 0
Jun 2020 23.9 0

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
Net Sales 121.9 145.56 164.06 179.51 200.6
Total Expenditure 108.8 128.41 141.79 156.39 169.73
Operating Profit 13.1 17.15 22.27 23.12 30.87
Other Income 3.41 5.56 8.28 4.6 4.53
Interest 22.99 13.09 14 12.78 12.5
Depreciation 21.85 21.85 21.63 21.25 20.97
Exceptional Items 0 0 -8.75 -144.35 0
Profit Before Tax -28.33 -12.23 -13.83 -150.66 1.93
Tax -9.6 -5.65 -0.82 2.56 0.53
Profit After Tax -18.73 -6.58 -13.01 -153.22 1.4
Adjusted EPS (Rs) -2.11 -0.53 -1.04 -12.22 0.11

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales 471.13 545.04 586.27 640.5 688.33
Total Expenditure 407.34 462.36 504.48 546.43 572.61
Operating Profit 63.8 82.67 81.78 94.07 115.73
Other Income 3.39 6.72 22.87 13.48 12.11
Interest 34.44 15.93 26.8 47.81 82.99
Depreciation 36.91 44.16 43.92 47.17 79.41
Exceptional Items -4.47 0 2.94 0 -30.89
Profit Before Tax -8.64 29.3 36.87 12.57 -65.46
Tax -3.91 9.82 11.98 5.32 -12.16
Net Profit -4.73 19.48 24.89 7.25 -53.3
Adjusted EPS (Rs.) -0.56 2.27 2.86 0.82 -6.01

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 85.08 85.71 86.9 87.92 88.69
Total Reserves 434.89 459.48 551.54 556.8 525.82
Borrowings 122.79 123.57 172.73 346.15 314.95
Other N/C liabilities -9.59 -6.91 26.76 42.91 347.51
Current liabilities 202.39 248.63 265.23 366.66 476.64
Total Liabilities 835.55 910.48 1103.17 1400.44 1753.61
Assets
Net Block 431.07 442.12 492 546.79 914.33
Capital WIP 28.57 33.41 79.11 104.11 43.61
Intangible WIP 0 0 0 0 0
Investments 94.67 133.93 218.85 299.04 316.13
Loans & Advances 49.86 53.18 91.83 122.73 147.07
Other N/C Assets 14.23 19.8 23.74 97.16 91.88
Current Assets 217.15 228.03 197.64 230.61 240.58
Total Assets 835.55 910.48 1103.17 1400.44 1753.61

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Profit from operations -8.64 29.3 36.87 12.57 -65.46
Adjustment 74.13 56.87 60.29 90.65 191.67
Changes in Assets & Liabilities -0.21 -25.17 -32.31 9.9 -20
Tax Paid -7.52 -7.06 1.49 -26.12 -19.87
Operating Cash Flow 57.76 53.94 66.35 86.99 86.34
Investing Cash Flow -85.54 -72.95 -184.61 -208.29 -116
Financing Cash Flow 120.05 -13.86 91.03 66.28 -2.76
Net Cash Flow 92.26 -32.87 -27.23 -55.02 -32.41

Corporate Actions

Investors Details

PARTICULARS Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
Public 27.48 14.47 13.48 13.33 15.48
il and fs trust company l... 1.64 1.16 1.16 1.16 1.16
gangadhara ganapati 1.21 0 0 0 0
hdfc life insurance compa... 1.51 0 0 0 0
qualified institutional b... 0 0.94 0 0 0
pivotal business managers... 1.4 0 0 0 0
zafar ahmadullah 1.7 1.2 1.2 1.2 1.2
gopi chand mamillapalli 0 0 0 0 1.44
PARTICULARS Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
FII/DII 48.62 18.62 19.65 15.96 16.11
buena vista asian opportu... 5.29 0 0 0 0
first state indian subcon... 0 0 0 0 0
franklin india smaller co... 0 0 0 0 0
indgrowth capital fund i 1.22 0 0 0 0
international finance cor... 4.91 3.48 3.48 3.48 3.48
nn (l) global equity impa... 4.23 0 0 0 0
the scottish oriental sma... 0 0 0 0 0
nn paraplufonds 1 n.v. 2.48 0 0 0 0
kotak equity opportunitie... 0 0 0 0 0
sundaram mutual fund a/c ... 8.68 0 0 0 0
v-sciences investments pt... 9.38 0 0 0 0
sundaram mutual fund a/c ... 0 6.14 0 0 0
wellington trust company,... 2.32 1.64 1.64 1.64 1.64
sundaram mutual fund a/c ... 0 0 6.09 2.91 0
tata mutual fund - tata s... 0 1.61 1.61 0 1.6
reliance capital trustee ... 1.29 0 0 0 0
tata india pharma & healt... 2.27 0 0 1.6 0
nn (l) prestige & luxe 0 0 0 0 0
icici prudential pharma h... 1.55 1.1 1.5 1.34 1.35
hdfc life insurance compa... 0 0 0 0 1.1
sundaram mutual fund a/c ... 0 0 0 0 2.88

HealthcareGlobal Stock Price Analysis and Quick Research Report. Is HealthcareGlobal an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the companys true net worth. This is generally done by examining the companys profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a companys performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a companys financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). HealthcareGlobal has a PE ratio of -17.5205015472176 which is low and comparatively undervalued .

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. HealthcareGlobal has ROA of -3.37959560513702 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a companys ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. HealthcareGlobal has a Current ratio of 0.504746779008852 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. HealthcareGlobal has a ROE of -8.55075067944592 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. HealthcareGlobal has a D/E ratio of 0.8028 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a companys inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. HealthcareGlobal has an Inventory turnover ratio of 47.7115131350939 which shows that the management is efficient in relation to its Inventory and working capital management.

  • Sales growth: - HealthcareGlobal has reported revenue growth of 7.46839573520022 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of HealthcareGlobal for the current financial year is 16.8123323851502 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for HealthcareGlobal is Rs 0 and the yield is 0 %.

Brief about HealthcareGlobal

Tell us about you

Find us at the office

Eastmond- Sukel street no. 62, 79540 Hanga Roa, Easter Island

Give us a ring

Jaquelinee Wrate
+74 201 709 645
Mon - Fri, 9:00-15:00

Reach out